𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Second primary malignancies in patients with neuroendocrine tumors

✍ Scribed by Reina, J. J.; Serrano, R.; Codes, M.; Jiménez, E.; Bolaños, M.; Gonzalez, E.; Sevilla, I.


Book ID
125378142
Publisher
Springer Milan
Year
2014
Tongue
Spanish
Weight
371 KB
Volume
16
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Second primary malignancies among patien
✍ Jianguang Ji; Kari Hemminki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 87 KB

## Abstract Survival from soft tissue tumors (STTs) has been improved because of the successful treatment. One of the late sequelae in STT survivors is the development of a second malignancy. The present study aimed at quantifying risks for second malignancies in patients with STTs, and risks for s

Second primary tumors in patients with c
✍ Smita Bhatia; Lilian Estrada-Batres; Tamara Maryon; Monica Bogue; David Chu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Several studies report coexistent or subsequent primary tumors (SPT) among patients with malignant melanoma (MM), with the rate of incidence ranging from 1.5-20% depending on the sample size and the length and completeness of follow-up. ## METHODS. The authors followed a cohort of patients with c

Liver embolizations of patients with mal
✍ B. K. Eriksson; E. G. Larsson; B. M. Skogseid; A. M. Löfberg; L. E. Lörelius; K. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. Patients with neuroendocrine gastrointestinal tumors usually present with inoperable metastatic disease and severe hormonal symptoms. Specific chemotherapy, interferon-␣ (IFN), and somatostatin analogs are established therapies for these patients, but all of them eventually fail. Hep

Second primary tumors in patients with o
✍ Gina L. Day; William J. Blot 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Background. Patients with cancer of the oral cavity and pharynx have been described to be particularly susceptible to the development of new cancers. Methods. Using data collected during 1973-1987 by nine population-based cancer registries in the United States, the authors evaluated risks of second